Kalidex Introduces Novel Fluoroquinolone, KPI-10, at the 52nd Interscience Conference on Antimicrobial Agents and …

MENLO PARK, Calif., Sept. 7, 2012 /PRNewswire/ — Kalidex Pharmaceuticals, a privately-held anti-infective company, today announced the presentation of data on its lead development candidate KPI-10, a …

Leave a Reply

Your email address will not be published.

*